Benzothiazolone derivative

Details for Australian Patent Application No. 2009336847 (hide)

Owner MERCK PATENT GMBH

Inventors Stieber, Frank; Schadt, Oliver; Dorsch, Dieter; Blaukat, Andree

Agent Griffith Hack

Pub. Number AU-A-2009336847

PCT Pub. Number WO2010/078905

Priority 10 2009 003 975.9 07.01.09 DE

Filing date 8 December 2009

Wipo publication date 15 July 2010

International Classifications

C07D 277/68 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 417/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/078905 Priority application(s): WO2010/078905

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009336851-Pyridazinone derivatives

2009336839-Novel polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4ylmethox y) - pyrimidin2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazi n-3-yl) -benzonitrile hydrochloride salt and processes of manufacturing thereof